The involvement of mitochondrial amidoxime reducing components 1 and 2 and mitochondrial cytochrome b5in N-reductive metabolism in human cells

Journal of Biological Chemistry

Volumn 288, Issue 28, 2013, Pages 20228-20237

  Plitzko, Birte ^a   Ott, Gudrun ^a   Reichmann, Debora ^b   Henderson, Colin J ^c   Roland Wolf, C ^c   Mendel, Ralf ^b   Bittner, Florian ^b   Clement, Bernd ^a   Havemeyer, Antje ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTRON TRANSPORT; EXPRESSION LEVELS; HUMAN CELL LINES; MAMMALIAN GENOMES; MITOCHONDRIAL CYTOCHROME B; MOLYBDENUM ENZYMES; SEQUENCE SIMILARITY; SINGLE NUCLEOTIDE POLYMORPHISMS;

CATALYSIS; CELL CULTURE; ENZYME ACTIVITY; HYDROXYLATION; MAMMALS; METABOLISM; PORPHYRINS;

PROTEINS;

AMIDOXIME REDUCING COMPONENT 1 PROTEIN; AMIDOXIME REDUCING COMPONENT 2 PROTEIN; CELL ENZYME; CYTOCHROME B5; HEME; HEMOPROTEIN; ISOPROTEIN; OXIDOREDUCTASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYSIS; CELL ACTIVITY; CELL COMPONENT; CELL METABOLISM; CONTROLLED STUDY; DETOXIFICATION; DOWN REGULATION; DRUG METABOLISM; ELECTRON TRANSPORT; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENETIC SIMILARITY; HUMAN; HUMAN CELL; HYDROXYLATION; KNOCKOUT MOUSE; MICROSOME; MITOCHONDRION; MOSC1 GENE; MOSC2 GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REDUCTION; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

CYB5B; DRUG METABOLISM; HEME; MARC; MITOCHONDRIA; MOLYBDENUM; MOSC; N-REDUCTION; RNA INTERFERENCE (RNAI);

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CYTOCHROME-B(5) REDUCTASE; CYTOCHROMES B5; HEK293 CELLS; HUMANS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MOLYBDENUM; MUTATION; OXIDATION-REDUCTION; OXIDOREDUCTASES; OXIMES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; RNA INTERFERENCE;

EID: 84880051185     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.474916     Document Type: Article

References (40)

1. Havemeyer, A., Lang, J., and Clement, B. (2011) The fourth mammalian molybdenum enzyme mARC: current state of research. Drug Metab. Rev. 43, 524-539
2. Havemeyer, A., Bittner, F., Wollers, S., Mendel, R., Kunze, T., and Clement, B. (2006) Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme. J. Biol. Chem. 281, 34796-34802 (Pubitemid 46036518)
3. Hille, R., Nishino, T., and Bittner, F. (2011) Molybdenum enzymes in higher organisms. Coord Chem. Rev. 255, 1179-1205
4. Gruenewald, S., Wahl, B., Bittner, F., Hungeling, H., Kanzow, S., Kotthaus, J., Schwering, U., Mendel, R. R., and Clement, B. (2008) The fourth molybdenum containing enzyme mARC: cloning and involvement in the activation of N-hydroxylated prodrugs. J. Med. Chem. 51, 8173-8177
5. Havemeyer, A., Grünewald, S., Wahl, B., Bittner, F., Mendel, R., Erdélyi, P., Fischer, J., and Clement, B. (2010) Reduction of N-hydroxy-sulfonamides, including N-hydroxy-valdecoxib, by the molybdenum-containing enzyme mARC. Drug Metab. Dispos. 38, 1917-1921
6. Froriep, D., Clement, B., Bittner, F., Mendel, R. R., Reichmann, D., Schmalix, W., and Havemeyer, A. (February 4, 2013) Activation of the anticancer agent upamostat by the mARC enzyme system. Xenobiotica 10.3109/00498254.2013. 767481
7. Krompholz, N., Krischkowski, C., Reichmann, D., Garbe-Schönberg, D., Mendel, R. R., Bittner, F., Clement, B., and Havemeyer, A. (2012) The mitochondrial amidoxime reducing component (mARC) is involved in detoxification of N-hydroxylated base analogues. Chem. Res. Toxicol. 25, 2443-2450
8. Mikula, M., Rubel, T., Karczmarski, J., Goryca, K., Dadlez, M., and Ostrowski, J. (2011) Integrating proteomic and transcriptomic high-throughput surveys for search of new biomarkers of colon tumors. Funct. Integr. Genomics 11, 215-224
9. Kotthaus, J., Wahl, B., Havemeyer, A., Kotthaus, J., Schade, D., Garbe-Schönberg, D., Mendel, R., Bittner, F., and Clement, B. (2011) Reduction of N(ω)-hydroxy-L-arginine by the mitochondrial amidoxime reducing component (mARC). Biochem. J. 433, 383-391
10. Malik, A. N., Rossios, C., Al-Kafaji, G., Shah, A., and Page, R. A. (2007) Glucose regulation of CDK7, a putative thiol related gene, in experimental diabetic nephropathy. Biochem. Biophys. Res. Commun. 357, 237-244 (Pubitemid 46574522)
11. 5 type B (CYB5B) and MOSC2 is of importance for lipid synthesis in adipocyte mitochondria. J. Biol. Chem. 287, 6307-6317
12. Aslibekyan, S., Goodarzi, M. O., Frazier-Wood, A. C., Yan, X., Irvin, M. R., Kim, E., Tiwari, H. K., Guo, X., Straka, R. J., Taylor, K. D., Tsai, M. Y., Hopkins, P. N., Korenman, S. G., Borecki, I. B., Chen, Y.-D. I., Ordovas, J. M., Rotter, J. I., and Arnett, D. K. (2012) Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate. PLoS ONE 7, e48663
13. Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., Johansen, C. T., Fouchier, S. W., Isaacs, A., Peloso, G. M., Barbalic, M., Ricketts, S. L., Bis, J. C., Aulchenko, Y. S., Thorleifsson, G., Feitosa, M. F., Chambers, J., Orho-Melander, M., Melander, O., Johnson, T., Li, X., Guo, X., Li, M., Shin Cho, Y., Jin Go, M., Jin Kim, Y., Lee, J.-Y., Park, T., Kim, K., Sim, X., Twee-Hee Ong, R., Croteau-Chonka, D. C., Lange, L. A., Smith, J. D., Song, K., Hua Zhao, J., Yuan, X., Luan, J., Lamina, C., Ziegler, A., Zhang, W., Zee, R. Y., Wright, A. F., Witteman, J. C., Wilson, J. F., Willemsen, G., Wichmann, H.-E., Whitfield, J. B., Waterworth, D. M., Wareham, N. J., Waeber, G., Vollenweider, P., Voight, B. F., Vitart, V., Uitterlinden, A. G., Uda, M., Tuomilehto, J., Thompson, J. R., Tanaka, T., Surakka, I., Stringham, H. M., Spector, T. D., Soranzo, N., Smit, J. H., Sinisalo, J., Silander, K., Sijbrands, E. J., Scuteri, A., Scott, J., Schlessinger, D., Sanna, S., Salomaa, V., Saharinen, J., Sabatti, C., Ruokonen, A., Rudan, I., Rose, L. M., Roberts, R., Rieder, M., Psaty, B. M., Pramstaller, P. P., Pichler, I., Perola, M., Penninx, B. W., Pedersen, N. L., Pattaro, C., Parker, A. N., Pare, G., Oostra, B. A., O'Donnell, C. J., Nieminen, M. S., Nickerson, D. A., Montgomery, G. W., Meitinger, T., McPherson, R., McCarthy, M. I., McArdle, W., Masson, D., Martin, N. G., Marroni, F., Mangino, M., Magnusson, P. K., Lucas, G., Luben, R., Loos, R. J., Lokki, M.-L., Lettre, G., Langenberg, C., Launer, L. J., Lakatta, E. G., Laaksonen, R., Kyvik, K. O., Kronenberg, F., König, I. R., Khaw, K.-T., Kaprio, J., Kaplan, L. M., Johansson, A., Jarvelin, M.-R., Janssens, A. C., Ingelsson, E., Igl, W., Kees Hovingh, G., Hottenga, J.-J., Hofman, A., Hicks, A. A., Hengstenberg, C., Heid, I. M., Hayward, C., Havulinna, A. S., Hastie, N. D., Harris, T. B., Haritunians, T., Hall, A. S., Gyllensten, U., Guiducci, C., Groop, L. C., Gonzalez, E., Gieger, C., Freimer, N. B., Ferrucci, L., Erdmann, J., Elliott, P., Ejebe, K. G., Döring, A., Dominiczak, A. F., Demissie, S., Deloukas, P., de Geus, E. J., de Faire, U., Crawford, G., Collins, F. S., Chen, Y.-D. I., Caulfield, M. J., Campbell, H., Burtt, N. P., Bonnycastle, L. L., Boomsma, D. I., Boekholdt, S. M., Bergman, R. N., Barroso, I., Bandinelli, S., Ballantyne, C. M., Assimes, T. L., Quertermous, T., Altshuler, D., Seielstad, M., Wong, T. Y., Tai, E.-S., Feranil, A. B., Kuzawa, C. W., Adair, L. S., Taylor, H. A., Borecki, I. B., Gabriel, S. B., Wilson, J. G., Holm, H., Thorsteinsdottir, U., Gudnason, V., Krauss, R. M., Mohlke, K. L., Ordovas, J. M., Munroe, P. B., Kooner, J. S., Tall, A. R., Hegele, R. A., Kastelein, J. J., Schadt, E. E., Rotter, J. I., Boerwinkle, E., Strachan, D. P., Mooser, V., Stefansson, K., Reilly, M. P., Samani, N. J., Schunkert, H., Cupples, L. A., Sandhu, M. S., Ridker, P. M., Rader, D. J., van Duijn, C. M., Peltonen, L., Abecasis, G. R., Boehnke, M., and Kathiresan, S. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713
14. Wahl, B., Reichmann, D., Niks, D., Krompholz, N., Havemeyer, A., Clement, B., Messerschmidt, T., Rothkegel, M., Biester, H., Hille, R., Mendel, R. R., and Bittner, F., (2010) Biochemical and spectroscopic characterization of the human mitochondrial amidoxime reducing components hmARC-1 and hmARC-2 suggests the existence of a new molybdenum enzyme family in eukaryotes. J. Biol. Chem. 285, 37847-37859
15. Da Cruz, S., Xenarios, I., Langridge, J., Vilbois, F., Parone, P. A., and Martinou, J.-C. (2003) Proteomic analysis of the mouse liver mitochondrial inner membrane. J. Biol. Chem. 278, 41566-41571 (Pubitemid 37280987)
16. Klein, J. M., Busch, J. D., Potting, C., Baker, M. J., Langer, T., and Schwarz, G. (2012) The mitochondrial amidoxime-reducing component (mARC1) is a novel signal-anchored protein of the outer mitochondrial membrane. J. Biol. Chem. 287, 42795-42803
17. Islinger, M., Lüers, G. H., Li, K. W., Loos, M., and Völkl, A. (2007) Rat liver peroxisomes after fibrate treatment: a survey using quantitative mass spectrometry. J. Biol. Chem. 282, 23055-23069 (Pubitemid 47311908)
18. Wiese, S., Gronemeyer, T., Ofman, R., Kunze, M., Grou, C. P., Almeida, J. A., Eisenacher, M., Stephan, C., Hayen, H., Schollenberger, L., Korosec, T., Waterham, H. R., Schliebs, W., Erdmann, R., Berger, J., Meyer, H. E., Just, W., Azevedo, J. E., Wanders, R. J., and Warscheid, B. (2007) Proteomics characterization of mouse kidney peroxisomes by tandem mass spectrometry and protein correlation profiling. Mol. Cell Proteomics 6, 2045-2057
19. 5 isoforms as models for the study of post-translational targeting to the endoplasmic reticulum. FEBS Lett. 325, 70-75
20. 5. Biochemistry 40, 9469-9483
21. 5 variant in humans with impaired hydroxylamine reduction capacity. Pharmacogenet. Genomics 17, 597-603
22. 5 reductase: genotype-phenotype correlations for hydroxylamine reduction. Pharmacogenet. Genomics 20, 26-37
23. Rhoads, K., Sacco, J. C., Drescher, N., Wong, A., and Trepanier, L. A. (2011) Individual variability in the detoxification of carcinogenic arylhydroxylamines in human breast. Toxicol. Sci. 121, 245-256
24. Sacco, J. C., Abouraya, M., Motsinger-Reif, A., Yale, S. H., McCarty, C. A., and Trepanier, L. A. (2012) Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity. Pharmacogenet. Genomics 22, 733-740
25. 5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. J. Biol. Chem. 273, 3158-3165
26. 5 or heme oxygenase. J. Biol. Chem. 276, 30885-30891
27. 5 via heterologous expression in Escherichia coli. Protein Expr. Purif. 66, 203-209
28. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
29. 5 profoundly affects hepatic and extrahepatic drug metabolism. Mol. Pharmacol. 78, 269-278
30. Estabrook, R. W., and Werringloer, J. (1978) The measurement of difference spectra: application to the cytochromes of microsomes. Methods Enzymol. 52, 212-220
31. Teale, F. W. (1959) Cleavage of the haem-protein link by acid methylethylketone. Biochim. Biophys. Acta 35, 543
32. Mulrooney, S. B., and Waskell, L. (2000) High-level expression in Escherichia coli and purification of the membrane-bound form of cytochrome b5. Protein Expr. Purif. 19, 173-178 (Pubitemid 30387908)
33. Wu, C., Orozco, C., Boyer, J., Leglise, M., Goodale, J., Batalov, S., Hodge, C. L., Haase, J., Janes, J., Huss, J. W., 3rd, and Su, A. I. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 10, R130
34. Andersson, S., Hofmann, Y., Nordling, A., Li, X. Q., Nivelius, S., Andersson, T. B., Ingelman-Sundberg, M., and Johansson, I. (2005) Characterization and partial purification of the rat and human enzyme systems active in the reduction of N-hydroxymelagatran and benzamidoxime. Drug Metab. Dispos. 33, 570-578 (Pubitemid 40393201)
35. Bernheim, M. L. (1972) The reduction of hydroxylamine and some aryl hydroxamates by liver mitochondria from mammals and birds. Enzymologia. 43, 167-176
36. Kadlubar, F. F., and Ziegler, D. M. (1974) Properties of a NADH-dependent N-hydroxy amine reductase isolated from pig liver microsomes. Arch. Biochem. Biophys. 162, 83-92
37. 5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans. J. Pharmacol. Exp. Ther. 311, 1171-1178
38. 5 heme propionates in the electrostatic binding to cytochrome c. Biochemistry 35, 16378-16390
39. 5 suggests novel targeting pathways. J. Biol. Chem. 268, 2802-2808
40. Clement, B., Mau, S., Deters, S., and Havemeyer, A. (2005) Hepatic, extrahepatic, microsomal, and mitochondrial activation of the N-hydroxylated prodrugs benzamidoxime, guanoxabenz, and Ro 48-3656([[1-[(2s)-2-[[4- [(hydroxyamino)iminomethyl]benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxy] -acetic acid). Drug Metab. Dispos. 33, 1740-1747